Two doses of a simple tuberculosis vaccine after surgery support the immune system in fighting cancer cells and could significantly improve treatment outcomes for the most common form of bladder cancer, according to a pilot study involving 40 patients. Initial results of the RUTIVAC-1 study were presented at EAU25.
Autoren
- Birke Dikken
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Case Report
76-year-old patient with pustular skin rash
- Sponsored Content: Psoriasis
Dauerhafte Erscheinungsfreiheit auch bei betroffenen speziellen Hautarealen
- Antithymocyte globulin in children with T1D
Old medicine, new hope
- Ginkgo biloba
Database of preclinical and clinical studies is becoming increasingly larger
- Digital biomarkers
Continuous monitoring using digital biomarkers in MS care
- Benefits, limits and safety aspects
Phytotherapy for cardiovascular diseases
- Results of the FOREST HCM study
Symptomatic obstructive hypertrophic cardiomyopathy
- Neuroprotection, resilience and cognitive health in old age